Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://scrip.pharmaintelligence.informa.com/SC146406/Small-Molecules-Attract-Investors-As-Two-Chinese-Biotechs-Bag-$161m
https://www.clinicaltrialsarena.com/news/reistone-atopic-dermatitis-trial/
https://www.prnewswire.com/news-releases/reistone-announces-positive-results-from-a-phase-ii-study-evaluating-shr0302-ointment-for-patients-with-mild-to-moderate-atopic-dermatitis-301396652.html
https://endpts.com/immunocores-bispecific-lands-speedy-review-with-fda-ema-low-profile-gene-therapy-player-grabs-30m/
https://www.prnewswire.com/news-releases/reistone-announces-positive-topline-phase-2-results-for-shr0302-a-selective-jak1-inhibitor-for-treatment-of-patients-with-alopecia-areata-301360967.html
https://www.prnewswire.com/news-releases/reistone-announces-first-patient-dosed-in-phase-iii-global-study-in-atopic-dermatitis-301290192.html
https://www.prnewswire.com/news-releases/positive-phase-2-results-for-reistones-jak-inhibitor-demonstrate-significant-improvement-in-patients-with-moderate-to-severe-ulcerative-colitis-301222353.html